Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Price (Quote)

$18.44
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $18.44 $18.44 Friday, 27th May 2022 TRIL stock ended at $18.44. During the day the stock fluctuated 0% from a day low at $18.44 to a day high of $18.44.
90 days $18.44 $18.44
52 weeks $5.80 $18.49

Historical Trillium Therapeutics Inc. prices

Date Open High Low Close Volume
Nov 29, 2021 $18.44 $18.44 $18.44 $18.44 0
Nov 26, 2021 $18.44 $18.44 $18.44 $18.44 0
Nov 24, 2021 $18.44 $18.44 $18.44 $18.44 0
Nov 23, 2021 $18.44 $18.44 $18.44 $18.44 0
Nov 22, 2021 $18.44 $18.44 $18.44 $18.44 0
Nov 19, 2021 $18.44 $18.44 $18.44 $18.44 0
Nov 18, 2021 $18.44 $18.44 $18.44 $18.44 8
Nov 17, 2021 $18.44 $18.44 $18.44 $18.44 40
Nov 16, 2021 $17.93 $18.49 $17.83 $18.45 24 915 908
Nov 15, 2021 $17.95 $17.97 $17.90 $17.97 873 736
Nov 12, 2021 $17.82 $17.91 $17.82 $17.90 909 939
Nov 11, 2021 $17.78 $17.91 $17.71 $17.82 1 309 700
Nov 10, 2021 $17.75 $17.96 $17.74 $17.83 1 255 100
Nov 09, 2021 $17.73 $17.90 $17.72 $17.83 1 613 300
Nov 08, 2021 $17.90 $17.99 $17.68 $17.69 1 809 029
Nov 05, 2021 $17.90 $18.00 $17.85 $17.88 1 193 461
Nov 04, 2021 $17.87 $17.94 $17.81 $17.85 1 029 900
Nov 03, 2021 $17.87 $17.93 $17.80 $17.85 789 300
Nov 02, 2021 $17.98 $18.03 $17.84 $17.86 1 093 700
Nov 01, 2021 $18.07 $18.12 $17.98 $18.00 1 672 066
Oct 29, 2021 $18.02 $18.12 $17.95 $18.11 625 646
Oct 28, 2021 $17.95 $18.00 $17.86 $17.94 510 300
Oct 27, 2021 $17.91 $18.00 $17.91 $17.94 629 200
Oct 26, 2021 $17.91 $17.97 $17.88 $17.96 572 200
Oct 25, 2021 $17.88 $17.96 $17.85 $17.91 513 999
Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT